Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu syndrome): update of September 22, 2026

A staged embolization strategy successfully treated a spinal AV fistula and a pulmonary AV malformation in one patient, showing effective targeted planning for complex cases.

Stereotactic radiosurgery is looked at for treating hard-to-reach brain AVMs, potentially offering better outcomes for some patients than traditional methods.

A new study plans to evaluate the effects of a treatment for severe nosebleeds in HHT patients, considering how individual factors may influence results.

A trial is exploring the role of body donation in studying HHT, which could provide important data on the disease's mechanisms and guide future treatment.

Research on cerebral AVMs suggests that changes in the vascular structure may be linked to risks of instability and complications, relevant for HHT treatments.

An accelerated radiosurgery approach for large brain AVMs shows promise by successfully reducing AVM size while minimizing radiation risks compared to earlier methods.

A study found that treating brain AVMs reduces long-term bleeding risks, which offers valuable data for deciding between surgery and observation.

Reviewing various treatments for nosebleeds in HHT patients suggests that some medications may significantly help manage bleeding episodes.

A case report describes a successful surgical approach for treating bilateral pulmonary AV malformations, emphasizing a viable option when other methods are challenging.

A case study highlights a SMAD4 mutation linked to gastric polyps, emphasizing the importance of genetic testing for proper diagnosis in similar patients.

Two new stem cell lines from HHT patients provide valuable resources for studying the genetic causes of the disease and potential treatment paths.

A systematic review compares outcomes of surgery versus monitoring in unruptured brain AVMs, aiming to clarify effective management strategies.

This research reviews a successful surgical method for managing giant AVMs in the head and neck, improving patient safety and quality of life.

A case shows a renal AVM in a young patient with high blood pressure, stressing the need for careful evaluation of rare vascular issues.

A microchip model mimicking HHT patient vascular lesions can help in studying the disease and exploring new treatment options.

A study on post-radiosurgery bleeding risk in brain AVMs identifies specific factors that could help doctors better manage treatment for HHT patients.